Basis of Therapeutic Nuclear Medicine
The Pathophysiologic Basis of Nuclear Medicine: Fourth Edition, Springer International Publishing Ag, ss.569-594, 2022
- Yayın Türü: Kitapta Bölüm / Araştırma Kitabı
- Basım Tarihi: 2022
- Doi Numarası: 10.1007/978-3-030-96252-4_13
- Yayınevi: Springer International Publishing Ag
- Sayfa Sayıları: ss.569-594
- Anahtar Kelimeler: Beta radiation, Bone metastasis, Medullary thyroid carcinoma, Peptide receptor radionuclide therapy, Radionuclide therapy
- Kırklareli Üniversitesi Adresli: Evet
Özet
Therapeutic applications of nuclear medicine are expanding. Until 5-10 years ago, the use of radioisotopes in therapy was limited predominantly to treatment of hyperthyroidism, thyroid cancer, polycythemia rubra vera, bone metastases (palliative), liver tumor/metastases, neuroblastoma, pheochromocytoma, and paragangliomas. In recent years, Lu-177 and Y-90 labeled somatostatin analogs, Lu-177 labeled PSMA ligands, and Ra-223 dichloride treatments have been increasingly used.